Page 31 - 南京医科大学自然版
P. 31
第44卷第6期 张丽君,李 琳,斯 岩,等. UBE2T通过JAK⁃STAT通路促进甲状腺乳头状癌细胞增殖[J].
2024年6月 南京医科大学学报(自然科学版),2024,44(6):762-768 ·767 ·
A 0.5 JAK STAT signaling pathway B TPC⁃1 KTC⁃1 sh⁃Vehicle sh⁃Vehicle
TPC⁃1
KTC⁃1
Enrichment score 0.4 0 p⁃STAT3 sh⁃Vehicle sh⁃Vehicle 86 kDa 2.5 sh⁃UBE2T 2.5 sh⁃UBE2T
sh⁃UBE2T
sh⁃UBE2T
0.3
0.2
2.0
2.0
0.1
STAT3
1.0
1.0
37 kDa
GAPDH 86 kDa Relative protein expression 1.5 *** Relative protein expression 1.5 ***
Ranked list metric 0.8 Low 0 p⁃STAT3 STAT3 0 p⁃STAT3 STAT3
0.5
0.5
High
1.0
0.6
0.4
0.2
0.0
-0.2
5 000 10 000 15 000 20 000 25 000 30 000
0
Rank in ordered data set
C TPC⁃1 KTC⁃1 D sh⁃UBE2T Colivelin+sh⁃UBE2T sh⁃UBE2T
sh⁃UBE2T sh⁃UBE2T Colivelin+sh⁃UBE2T
1.0 1.0
Colivelin+sh⁃UBE2T Colivelin+sh⁃UBE2T 200 *
nm) 0.8 *** nm) 0.8 ** TPC⁃1 150
(450 0.6 (450 0.6 Number of colonies 100 *
0.4
0.4
D
D
0.2
0 0.2 0 KTC⁃1 50
0 24 48 72 0 24 48 72 0
Time(h) Time(h) TPC⁃1 KTC⁃1
E TPC⁃1 F KTC⁃1
sh⁃UBE2T Colivelin+sh⁃UBE2T sh⁃UBE2T Colivelin+sh⁃UBE2T
(%) 150 TPC⁃1 (%) 150 KTC⁃1
Wound closure rate 50 0 Wound closure rate 50
0 h 100 h 0 100
0
sh⁃UBE2T
sh⁃UBE2T
h Colivelin+sh⁃UBE2T h Colivelin+sh⁃UBE2T
24 24
G Migration H Invasion
sh⁃UBE2T Colivelin+sh⁃UBE2T sh⁃UBE2T Colivelin+sh⁃UBE2T
sh⁃UBE2T sh⁃UBE2T
Colivelin+sh⁃UBE2T Colivelin+sh⁃UBE2T
TPC⁃1 60 TPC⁃1 60
Migration cells per field 40 Invasion cells per field 40
20
20
KTC⁃1 0 TPC⁃1 KTC⁃1 KTC⁃1 0 TPC⁃1 KTC⁃1
A:The gene set enrichment analysis(GSEA)of UBE2T in the TCGA dataset(normalized enrichment score=1.83,P < 0.01,false discovery rate=
0.02). B:The results of Western blot analysis and quantivication to assess changes in phosphorylation levels of PTC cells(TPC⁃1 and KTC⁃1)after
UBE2T knockdown. C:The CCK⁃8 assay was used to evaluate the proliferative ability of sh⁃UBE2T cells(TPC⁃1 and KTC⁃1)treated with Colivelin.
D:The colony formation assay was used to measure the clonogenic potential of sh⁃UBE2T cells(TPC⁃1 and KTC⁃1)treated with Colivelin. E,F:The
wound healing assay was used to evaluate the migration abilities of sh⁃UBE2T cells treated with Colivelin(E:TPC⁃1;F:KTC⁃1;×40). G,H:The
transwell assay was used to evaluate the migration(G)and invasion(H)abilities of sh⁃UBE2T cells(TPC⁃1 and KTC⁃1)treated with Colivelin(×100).
* ** ***
P < 0.05,P < 0.01 and P < 0.001(n=3).
图4 UBE2T通过激活JAK⁃STAT信号通路促进PTC细胞增殖
Figure 4 The promotion of PTC cell proliferation by UBE2T through activation of the JAK ⁃ STAT signaling pathway